These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11114138)

  • 1. The pathologist's view point. Part II --aggressive lymphomas.
    Pileri SA; Ascani S; Sabattini E; Fraternali-Orcioni G; Poggi S; Piccioli M; Piccaluga PP; Gamberi B; Zinzani PL; Leoncini L; Falini B
    Haematologica; 2000 Dec; 85(12):1308-21. PubMed ID: 11114138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathologist's view point. Part I--indolent lymphomas.
    Pileri SA; Ascani S; Sabattini E; Fraternali-Orcioni G; Poggi S; Piccioli M; Piccaluga PP; Gamberi B; Zinzani PL; Leoncini L; Falini B
    Haematologica; 2000 Dec; 85(12):1291-307. PubMed ID: 11114137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current lymphoma classification: a step forward for pathologists and clinicians].
    de Jong D; Kluin PM
    Ned Tijdschr Geneeskd; 1997 Aug; 141(33):1601-13. PubMed ID: 9543765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary skin lymphomas: phenotypic characteristics of major clinical variants, classification].
    Vavilov AM; Lezvinskaia EM
    Arkh Patol; 1998; 60(2):3-7. PubMed ID: 9612501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification of lymphomas].
    Molina T; Diebold J; Audouin J
    Rev Prat; 2002 May; 52(9):951-8. PubMed ID: 12063760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic phenotype of malignant lymphoma].
    Tobinai K; Shimoyama M
    Nihon Rinsho; 1992 Jun; 50(6):1223-8. PubMed ID: 1518137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
    Milner RJ; Pearson J; Nesbit JW; Close P
    Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant lymphomas of the gastro-intestinal tract: a reappraisal on the basis of the newly proposed Revised European American Lymphoma Classification.
    Pileri S; Piccaluga PP; De Vivo A; Sabattini E; Poggi S; Melilli G; Falini B; Piccaluga A
    Ital J Gastroenterol; 1994; 26(8):405-18. PubMed ID: 7703515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
    Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
    Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
    [No Abstract]   [Full Text] [Related]  

  • 11. The World Health Organization classification of lymphomas.
    Jakić-Razumović J; Aurer I
    Croat Med J; 2002 Oct; 43(5):527-34. PubMed ID: 12402390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Classification and differential diagnosis of B-cell lymphomas].
    Anagnostopoulos I
    Verh Dtsch Ges Pathol; 2003; 87():32-42. PubMed ID: 16888892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
    Nakamura S
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular findings and classification of malignant lymphomas.
    Pileri SA; Ceccarelli C; Sabattini E; Santini D; Leone O; Damiani S; Leoncini L; Falini B
    Acta Haematol; 1996; 95(3-4):181-7. PubMed ID: 8677740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The 2008 WHO lymphoma classification].
    Delsol G
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S20-4. PubMed ID: 18984289
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
    Lee MY; Tan TD; Feng AC; Liu MC
    Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral NK/T-cell lymphoma].
    Rüdiger T; Zettl A; Adam P; Bonzheim I; Geissinger E; Müller-Hermelink HK
    Pathologe; 2007 Feb; 28(1):55-8. PubMed ID: 17195040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification.
    Chinen K; Izumo T
    Ann Hematol; 2005 Aug; 84(8):498-505. PubMed ID: 15782345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
    Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
    Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.